Danaher (DHR) Debt Ratio (2009 - 2026)

Danaher (DHR) posted Debt Ratio of 0.3 for Q2 2026, up 30.35% on a QoQ basis from 0.23 in Q1 2026, and up 38.4% year-over-year from 0.22 in Q2 2025.

Analysis

Danaher (DHR) Debt Ratio (2009 - 2026) Analysis & Trends

Danaher has reported Debt Ratio for 18 years, with the latest figure at 0.3 in Q2 2026.

On a quarterly basis, Debt Ratio rose 38.4% year-over-year to 0.3 in Q2 2026; TTM through Jun 2026 was 0.3, a 38.4% increase from a year earlier, with the FY2025 full-year figure at 0.22, up 3.65% from the prior year.
Debt Ratio was 0.3 for Q2 2026 at Danaher, up from 0.23 in the prior quarter.
The five-year high for Debt Ratio was 0.3 in Q2 2026, with the low at 0.21 in Q3 2025.
Average Debt Ratio over 5 years is 0.24, with a median of 0.24 recorded in 2024.
The sharpest annual moves came in 2024 and 2026: Debt Ratio fell 17.19% in 2024, then jumped 38.4% in 2026.
Over 5 years, Debt Ratio stood at 0.24 in 2022, then decreased by 1.01% to 0.24 in 2023, then dropped by 10.49% to 0.21 in 2024, then grew by 3.65% to 0.22 in 2025, then soared by 37.2% to 0.3 in 2026.
The last three Debt Ratio figures came in at 0.3 (Q2 2026), 0.23 (Q1 2026), and 0.22 (Q4 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Thermo Fisher Scientific	241.68 Bn	237.61 Bn	8.34 Bn	0.40
2	Danaher	147.34 Bn	142.99 Bn	3.61 Bn	0.30
3	Agilent Technologies	43.34 Bn	41.59 Bn	1.04 Bn	0.30
4	Illumina	34.58 Bn	33.41 Bn	770.00 Mn	0.30
5	Revvity	16.31 Bn	15.29 Bn	416.87 Mn	0.27
6	Bio-Techne	11.28 Bn	11.01 Bn	211.39 Mn	0.08
7	Bio-Rad Laboratories	10.16 Bn	8.54 Bn	345.80 Mn	0.16
8	Repligen	9.77 Bn	8.75 Bn	110.04 Mn	0.19
9	10x Genomics	9.45 Bn	8.90 Bn	112.50 Mn	-
10	Bruker	9.26 Bn	9.04 Bn	416.00 Mn	0.30

Historic Data

Download Data